Please login to the form below

Not currently logged in
Email:
Password:

Ashfield appoints new leaders in the US and Japan

Greg Flynn and Mick O’Leary take up regional president roles

Greg FlynnUDG Healthcare subsidiary Ashfield has appointed Greg Flynn (pictured right) as US regional president of its commercial and clinical division in a role that will see him deliver commercial, clinical, pharmacovigilance and market access operations.

Julian Tompkins, global president for Ashfield’s clinical and commercial business, said: “Greg’s leadership in the Japanese market has yielded remarkable growth and proven his dedication to Ashfield’s success.

“With Greg’s innovative thinking and focus on people, we are looking forward to seeing his impact on the US business.”

Flynn is transitioning from his prior position as regional president in Japan and representative director of CMIC Ashfield - a joint initiative between CMIC Holdings and UDG Healthcare.

He said: “Through the talent of our people and Ashfield’s commitment to helping improve lives, I have seen the power of what we do in this organisation.

“The US business has experienced phenomenal growth in the last two years and this new role is an exciting opportunity to continue that growth.

“I am excited about the future of Ashfield in the US and being part of the next phase in this company’s journey.”

Mick O'LearyMick O’Leary (pictured left) takes on Flynn’s previous role in the group’s Japan office as regional president of the commercial and clinical division, leading the CMIC Ashfield venture.

He said: “I am delighted to accept the role of regional president in Japan and support the group’s overall strategy of expansion in growth markets.

“CMIC Ashfield is a winning proposition, combining the experience and expertise of a leading international CSO, with the local knowledge and capability of one of Japan’s leading CSOs.

“We’ll continue to excel by providing flexible, evidence-based services and I look forward to working with new clients and brand challenges in Japan.”

O’Leary previously served as the managing director for Ashfield Ireland, and has over 20 years’ experience in the pharmaceutical sales industry.

Tompkins added: “ The appointment of Mick O’Leary as regional president in Japan will continue our success story and excellent results in the second largest global pharmaceutical market.

“He has exactly the right expertise and drive to lead CMIC Ashfield and continue our strong progress in Japan.”

20th June 2017

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Future Market Insights

Future Market Insights is the premier provider of market intelligence and consulting services, serving clients in over 150 countries. FMI...

Latest intelligence

OUTiCO win Best in UK Pharmaceutical Outsourcing award
The Corporate LiveWire Healthcare and Life Sciences Awards celebrate global companies and individuals who have excelled over the past 12 months....
artificial-intelligence-in-healthcare.jpg
Artificial Intelligence in Healthcare
Artificial intelligence is already out-diagnosing experts, but would you put a computer in charge of your healthcare? The good, the bad; we take a look....
World Pancreatic Cancer Day 2018: Combating misconceptions in pancreatic cancer
Patients diagnosed with pancreatic cancer face a dismal prognosis, with the disease having the lowest survival rate of all major cancers. In spite of this, pancreatic cancer research is chronically...

Infographics